Learn more

DRACO AB

Overview
  • Total Patents
    904
About

DRACO AB has a total of 904 patent applications. Its first patent ever was published in 1966. It filed its patents most often in Sweden, Norway and Finland. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are IKARIA INC, NEURALIGHT HD LLC and MEDDISS INC.

Patent filings per year

Chart showing DRACO ABs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Wetterlin Kjell Ingvar Leopold 176
#2 Axelsson Bengt Ingemar 74
#3 Trofast Jan William 71
#4 Svensson Leif Ake 59
#5 Olsson Otto Agne Torsten 59
#6 Thalen Bror Arne 57
#7 Andersson Per Ture 46
#8 Wetterlin Kjell I L 45
#9 Andersson Jan Anders Roland 43
#10 Virtanen Risto 42

Latest patents

Publication Filing date Title
HK7197A Process for the preparation of intermediates for 11-beta, 16-alpha, 17-alpha, 21-tetra-hydroxypregna-3, 20-dione 16-alpha, 17-alpha-acetals and 21-esters thereof
US5531590A Shock-stabilized supersonic flame-jet method and apparatus
US5643602A Oral composition for the treatment of inflammatory bowel disease
LV5527A3 Saturation of steroid esters
LV5458A3 Attenuation to obtain aminoethanol derivatives or their islands
LV5526A3 Sediment for obtaining androstan-17beta-carbohydrate esters
US5350767A Derivatives of cysteine
CN1060471A New 16, the 17-acetal replaces the preparation method of etioallocholane-17 β-ketone
US5215979A 16,17-acetalsubstituted pregnane 21-oic acid derivatives
FI910379A0 Process for preparing 16,17-acetal-substituted androstane derivatives
JO1635B1 New bronchospasmolytic Compounds and Process for their preparation
WO9013538A1 Organic salts of cysteine derivatives
RU2051901C1 Derivatives of 1-benzylaminophenyl-2-(1-methyl-2-phenylethylamino)-ethanol as mixture of isomers or as racemate or their pharmaceutically acceptable salts having bronchospasmolytic activity
AU5067590A New bronchospasmolytic compounds and process for their preparation
EP0387222A1 Device in connection with an inhaler
SE8903914D0 ORAL COMPOSITION FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES
JO1592B1 New derivatives of cysteine
CA1334845C 16,17-acetalsubstituted androstane-17.beta.-carboxylic acid esters
AU2718188A A device for filling a solution into a nasal cavity
WO8905163A1 A device for filling a solution into a nasal cavity